Eli Lilly has emerged as a popular growth stock thanks to its strength in the weight loss space. But the pharma giant also has an enormous opportunity in the Alzheimer's Disease market.

In the latest trading session, Eli Lilly (LLY) closed at $852.35, marking a -1.45% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.16%. On the other ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

In honor of Equal Pay Day, PEOPLE has the exclusive first trailer for 'Lilly,' starring Patricia Clarkson Sharareh Drury is a writer on the Movies team at PEOPLE. She joined PEOPLE in 2025 and has ...

Weight loss drugs such as Mounjaro help the body manage blood sugar more effectively, make one feel less hungry, and slow digestion, so the person feels full longer. Mounjaro, chemically known as ...

Atria is a Dividend King with an impressive track record for dividend growth. Eli Lilly has been raising its dividend at a more impressive pace than Altria in recent years. Altria has an ...

MNC pharma major Eli Lilly has launched Mounjaro (tirzepatide), a weekly injection for obesity and type 2 diabetes, after obtaining approval from India’s Central Drugs Standard Control ...

In this article, we are going to take a look at where Eli Lilly And Company (NYSE:LLY) stands against other stocks that may be splitting soon. Stock splits change the number of outstanding shares ...

Collins' husband Charlie McDowell also dedicated a sweet post to the actress, writing that he and their baby girl Tove "are so lucky to have you in our lives" Lily Collins/Instagram Lily Collins ...

The trial results are among the pharmaceutical industry's most critical and closely watched of the year, as they bring Eli Lilly's drug one step closer to becoming a new, needle-free alternative ...

American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity management drug Mounjaro (tirzepatide) in India. The company launched the drug in ...

Lilly beats Novo Nordisk to launch weight-loss drug in India Mounjaro's 5 mg vial priced at around $50, 2.5 mg at about $40 Drug's pricing may limit accessibility in India, analyst says Novo's ...